Publications
View AllAdjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer
Among patients with high-risk, HER2-negative early breast cancer and germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic or likely pathogenic variants, adjuvant olaparib after comp...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- US
- Publications
- 2
- Citations
- 3,601
External Links
Identifiers
- ROR
- https://ror.org/01g63ab19